Minea Radu O相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Potent Therapeutic Activity of NEO212 in Preclinical Models of Human and Canine Leukaemia and Lymphoma

NEO212在人类和犬白血病和淋巴瘤的临床前模型中表现出强大的治疗活性

期刊:Veterinary and Comparative Oncology

影响因子:1.9

doi:10.1111/vco.13066

Chen, Thomas C; Swenson, Steve; Thein, Thu Zan; Minea, Radu O; Schönthal, Axel H

发表日期：2025

文献求助收藏

NEO212, temozolomide conjugated to NEO100, exerts superior therapeutic activity over temozolomide in preclinical chemoradiation models of glioblastoma

NEO212（替莫唑胺与NEO100的偶联物）在胶质母细胞瘤的临床前放化疗模型中，其治疗活性优于替莫唑胺。

期刊:NeuroOncology Advances

影响因子:4.1

doi:10.1093/noajnl/vdae095

Minea, Radu O; Thein, Thu Zan; Yang, Zhuoyue; Campan, Mihaela; Ward, Pamela M; Schönthal, Axel H; Chen, Thomas C

细胞生物学

发表日期：2024

文献求助收藏

Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies

在脑部局部恶性肿瘤小鼠模型中，动脉内注射NEO100可促进检查点抑制治疗性抗体进入大脑。

期刊:Journal of Neurosurgery

影响因子:3.6

doi:10.3171/2022.12.JNS221285

Wang, Weijun; He, Haiping; Zeng, Shan; Cho, Hee-Yeon; Minea, Radu O; Swenson, Steven D; Zheng, Long; Epstein, Alan L; Stathopoulos, Apostolos; Chen, Ligang; Schönthal, Axel H; Chen, Thomas C

发表日期：2023

文献求助收藏

Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

Vicrostatin——一种抗侵袭性多整合素靶向嵌合解整合素，具有肿瘤抗血管生成和促凋亡活性

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0010929

Minea Radu O, Helchowski Corey M, Zidovetzki Samuel J, Costa Fritz K, Swenson Stephen D, Markland Francis S Jr

发表日期：2010

文献求助收藏